Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending June 2014. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in their interests in the company's ordinary shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The material change disclosed is the acquisition of ordinary shares by a connected person:
- Connected Person: Mr P C Thomson and Mrs K Thomson.
- Transaction Date: June 10, 2014.
- Price: 1598.59 pence per Ordinary Share.
- Quantity: Acquisition of 2 Ordinary Shares under the personal contribution element and 2 Ordinary Shares under the matching element (Company contribution) of the ShareReward Plan.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the share purchase in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
Key Facts for Investor Verification
- Verify the total number of shares held by Mr P C Thomson and Mrs K Thomson following this transaction.
- Confirm the terms of the ShareReward Plan regarding the matching contribution ratio.
- Check for any other concurrent transactions by directors or connected persons during the same period.